Expand / Collapse search
Watch TV
Menu

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by Refinitiv Lipper.

Coronavirus

EU considering combined COVID vaccine approval, according to German health minister

New combined vaccines may be approved soon, according to German health minister

Associated Press
Published
close
Fox News Flash top headlines for August 15 Video

Fox News Flash top headlines for August 15

Fox News Flash top headlines are here. Check out what's clicking on Foxnews.com.

Germany's health minister said Friday that European Union drug regulators may authorize the use of vaccines that are each effective against two variants of the coronavirus.

German Health Minister Karl Lauterbach said he expected the European Medicines Agency to meet Sept. 1 to consider a vaccine that would provide protection against the original virus and the omicron variant, also known as BA.1.

The EU agency would likely meet again on Sept. 27 to review a combined vaccine against the original virus and the BA.5 variant that is responsible for the latest global surge in COVID-19 cases, Lauterbach said.

EU URGES SECOND COVID-19 BOOSTERS FOR PEOPLE AGES 60 TO 79

Germany has procured sufficient amounts of both vaccines and would be able to start rolling them out a day after they received authorization, he said.

German Health Minister Karl Lauterbach

German Health Minister Karl Lauterbach, pictured, announced that EU drug regulators are considering approving vaccines that protect against the original COVID-19 stain as well as the omicron variant. Photo taken in Berlin, Germany, on Aug. 12, 2022. (AP Photo/Michael Sohn)

The U.S. Food and Drug Administration has said that combination vaccines, known as "bivalent" or "multivalent" shots, will allow boosters to retain the proven benefits of original coronavirus vaccines while providing additional protection against new variants.

Such an approach is used with flu shots, which are adjusted each year depending on the variants that are circulating and can protect against four influenza strains.

Lauterbach, a trained epidemiologist, said the potential for the coronavirus to keep mutating remained high.

COVID-19: EUROPE CONSIDERS ACCEPTING THE VIRUS

"There are still very many variants that could develop," he said, noting the large number of infections worldwide, including among people with weakened immune systems that allow the virus to persist for months.